title: Potential beneficial effect of low-dose danazol in combination with renin-angiotensin system inhibitors in diabetic macular oedema.
authors.affiliation: Ampio Pharmaceuticals, Inc., Greenwood Village, Colorado, USA.|Trauma Research Department, Swedish Medical Center, Englewood, Colorado, USA.|Trauma Research Department, St. Anthony Central Hospital, Denver, Colorado, USA.|Trauma Research Department, The Medical Center of Plano, Plano, Texas, USA.
authors.forename: David
authors.identifier: 0000-0002-3685-314X
authors.initials: D
authors.lastname: Bar-Or
authors.affiliation: Trauma Research Department, Swedish Medical Center, Englewood, Colorado, USA.|Trauma Research Department, St. Anthony Central Hospital, Denver, Colorado, USA.|Trauma Research Department, The Medical Center of Plano, Plano, Texas, USA.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Orlando
authors.affiliation: Ophthalmology Department, University of Texas Health Science Center, San Antonio, Texas, USA.|Medical Center Ophthalmology Associates, San Antonio, Texas, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Singer
mesh_terms: D000284:Administration, Oral; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D003613:Danazol / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004965:Estrogen Antagonists / Q000008:administration & dosage; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004965:Estrogen Antagonists; D003613:Danazol